-
Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
How long before they sell the company?
Discussion in 'Exact Sciences' started by Anonymous, Mar 15, 2015 at 9:47 PM.